Literature DB >> 17541103

Effects of antidepressant treatment following myocardial infarction.

Joost P van Melle1, Peter de Jonge, Adriaan Honig, Aart H Schene, Astrid M G Kuyper, Harry J G M Crijns, Annique Schins, Dorien Tulner, Maarten P van den Berg, Johan Ormel.   

Abstract

BACKGROUND: Depression following myocardial infarction is associated with poor cardiac prognosis. It is unclear whether antidepressant treatment improves long-term depression status and cardiac prognosis. AIMS: To evaluate the effects of antidepressant treatment compared with usual care in an effectiveness study.
METHOD: In a multicentre randomised controlled trial, 2177 myocardial infarction patients were evaluated for ICD-10 depression and randomised to intervention (n=209) or care as usual (n=122). Both arms were evaluated at 18 months post-myocardial infarction for long-term depression status and new cardiac events.
RESULTS: No differences were observed between intervention and control groups in mean scores on the Beck Depression Inventory (11.0, s.d.=7.5 v.10.2, s.d.=5.1, P=0.45) or presence of ICD-10 depression (30.5 v. 32.1%, P=0.68). The cardiac event rate was 14% among the intervention group and 13% among controls (OR=1.07, 95% CI 0.57-2.00).
CONCLUSIONS: Antidepressant treatment did not alter long-term depression post-myocardial infarction status or improve cardiac prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541103     DOI: 10.1192/bjp.bp.106.028647

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  73 in total

Review 1.  Is there a high-risk subtype of depression in patients with coronary heart disease?

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 2.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

3.  Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.

Authors:  Karina W Davidson; Matthew M Burg; Ian M Kronish; Daichi Shimbo; Lucia Dettenborn; Roxana Mehran; David Vorchheimer; Lynn Clemow; Joseph E Schwartz; Francois Lespérance; Nina Rieckmann
Journal:  Arch Gen Psychiatry       Date:  2010-05

Review 4.  Depression in patients with heart disease: the case for more trials.

Authors:  Stanley S Liu; Roy C Ziegelstein
Journal:  Future Cardiol       Date:  2010-07

Review 5.  Effects of exercise and physical activity on depression.

Authors:  P C Dinas; Y Koutedakis; A D Flouris
Journal:  Ir J Med Sci       Date:  2010-11-14       Impact factor: 1.568

Review 6.  Management of depression after myocardial infarction.

Authors:  Peter A Shapiro
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

Review 7.  Treatment-resistant depression and mortality after acute coronary syndrome.

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

8.  Effective treatment of depression improves post-myocardial infarction survival.

Authors:  Soudabeh Khojasteh Banankhah; Erika Friedmann; Sue Thomas
Journal:  World J Cardiol       Date:  2015-04-26

9.  Clinical predictors of depression treatment outcomes in patients with coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland; Brian C Steinmeyer; Eugene H Rubin; Michael W Rich
Journal:  J Psychosom Res       Date:  2016-07-19       Impact factor: 3.006

10.  Prospects of psychosomatic medicine.

Authors:  Gen Komaki; Yoshiya Moriguchi; Tetsuya Ando; Kazuhiro Yoshiuchi; Mutsuhiro Nakao
Journal:  Biopsychosoc Med       Date:  2009-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.